Correction: Arce-Huamani et al. Efficacy and Safety of Apixaban versus Dalteparin as a Treatment for Cancer-Associated Venous Thromboembolism: A Systematic Review and Meta-Analysis. Medicina 2023, 59, 1867

Medicina (Kaunas). 2024 Jan 11;60(1):134. doi: 10.3390/medicina60010134.

Miguel A Arce-Huamani^{1

2}, Joshuan J Barboza³, José Fabián Martínez-Herrera^{2

4}, J Smith Torres-Roman^{2

5}, Jorge L Maguiña¹

¹ Facultad de Ciencias de la Salud, Universidad Cientifica del Sur, Lima 15067, Peru.
² Cancer Research Networking, Universidad Cientifica del Sur, Lima 15067, Peru.
³ Centro de Investigación en Epidemiología y Medicina Basada en Evidencia, Universidad Norbert Wiener, Lima 13007, Peru.
⁴ Cancer Center, Medical Center American British Cowdray, Mexico City 01120, Mexico.
⁵ Latin American Network for Cancer Research (LAN-CANCER), Lima 11702, Peru.

Abstract

There was an error in the original publication [...].